Portola Pharmaceuticals, Inc. (NASDAQ:PTLA) have diverse level of ownership with Puma Biotechnology, Inc. (NASDAQ:PBYI). The circumstantial evidence specially high/lower types of ownership has a vital gauge for investing research process and it should be done carefully, as rather than offering …
0 Comments